13-03-2012 11:07 Multiple sclerosis can be difficult to diagnose. Dr. Steven Bromley discussesdiagnosis and management of the disease, and the continuum of care Virtua Neurosciences offers patients -- enabling them to live healthy, happy lives. See the original post here: Managing multiple sclerosis - Video … Continue reading →

Yukoners with multiple sclerosis have a chance to participate in clinical trials for a controversial treatment. There are up to six secured spots for Yukoners for the so-called 'liberation treatment' clinical trials in Albany, New York. Initially, the territory was to take part in clinical trials in Saskatchewan. Jenny Roberts, the president of the Yukon Multiple Sclerosis Association, says its members urged the Yukon Government to get in on the treatment at the beginning. "We usually get ignored because of our geographical location, so that was our pressure that we did put on them, that, 'don't exclude us and if we have an opportunity we have to explore it'. And the YTG (Yukon Territorial Government), Minister of Health and the deputy minister has listened and worked with us very closely to get to this point," she said. Roberts says the association's members are very excited about the chance to participate in the trials. Applicants must be between 18 and 60 years old, have a valid passport and they cannot have had past liberation treatments. The therapy is also known as Zamboni therapy after it was pioneered by Italian doctor Paolo Zamboni. Zambonis procedure uses angioplasty to widen neck veins. His … Continue reading →

LONDON, March 14, 2012 /PRNewswire/ -- Limited awareness about the disease and its overall occurrence and progression among end-users is hampering the European multiple sclerosis (MS) market. This is being exacerbated by the limited availability of accurate diagnostic tools. There is, therefore, an immediate need for innovative and enhanced therapeutic and diagnostic tools that support improved diagnosis and expand the range of treatment options. New analysis from Frost & Sullivan (http://www.pharma.frost.com), Analysis of the European Multiple Sclerosis Market, finds that the market earned revenues of approximately $3.2 billion in 2010 and estimates this to reach approximately $5.38 billion in 2017, growing at a compound annual growth rate (CAGR) of 7.2 per cent from 2010-2017. The segments covered include: immunosuppressants, immunomodulators and corticosteroids. "The rising number of people suffering from MS is resulting in higher demand for therapeutics," notes Frost & Sullivan Research Analyst Deepika Pramod Chopda. "This, coupled with strong pipeline development, is pushing robust growth in the overall market." MS is characterised as a chronic disease, commonly diagnosed in patients between 20-50 years of age. It affects more than 2.5 million people across the world, with Europe accounting for nearly 550,000 cases. Significant research is currently underway to efficiently … Continue reading →

The National Multiple Sclerosis Society, North Florida Chapter is painting the town orange the official color of MS awareness during Multiple Sclerosis Awareness Week which concludes Sunday. MS Awareness Week will kicked off Monday. with an awareness and fundraising event at Bogey Grille in Ponte Vedra Beach, where the public was invited to a free screening of the movie The Ride starring The Amazing Race host Phil Keoghan cycling across the country to raise awareness for the National MS Society and Bike MS. A portion of the proceeds raised from the evenings food and beverage sales will benefit the National MS Society. Also on Monday the Alhambra Theatre spread MS awareness by lighting the garden and front yard of the theatre in orange through Sunday. The door man will also don orange attire and information about MS, the Society and Walk MS one of the Societys main annual fundraisers will be displayed. In addition, more than 50 people in the North Florida are registered with the Chapter as MS Ambassadors who will receive prizes and materials to help raise awareness in the 36 counties that the North Florida Chapter serves. They will spread awareness through email, social media and by … Continue reading →

Yukoners suffering from multiple sclerosis (MS) will have the chance to undergo clinical trials of the liberation treatment. About six Yukon residents will be chosen for the controversial treatment in Albany, N.Y., after passing a series of screenings. The procedure uses angioplasty to widen blood vessels, and is reported to improve everything from eyesight to fatigue. Its not yet legal in Canada, and many Canadians have flown to places like Costa Rica and India to undergo the procedure. Were all patting ourselves on the back for all the hard work weve done to get to this point, Jenny Roberts, a Whitehorse resident with MS and the president of the territorys MS association, told the Star today. Roberts said the association invited then-Health and Social Services minister Glen Hart and deputy minister Stuart Whitley to a monthly meeting a year ago. They wanted to learn whether the government would send Yukoners to Saskatchewan to participate in the provinces trials. The government agreed to partnering with the Saskatchewan Health Research Foundation by sending about a dozen Yukoners down south for trials. But they never happened. Once the trials fell through, we were concerned what would happen, Roberts said. These new trials involve … Continue reading →